{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"fnip1-associated","columns":[{"gene":"","key":"population-91a634031e19fe32178c","label":"Immunodeficiency 93 and hypertrophic cardiomyopathy","mondoId":"MONDO:0100432","onsetQualifier":null,"originColumnKey":"MONDO:0100432/OMIM:619705","originalViews":[{"key":"MONDO:0100432/OMIM:619705","label":"Immunodeficiency 93 and hypertrophic cardiomyopathy","scopeLabel":"OMIM:619705","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["0b8c54c72e791a03837b0208d351edb23b0e0805465cfb254bafd8e0d03ecf3b","0bcf8b056380cb72e41bb56960a4431542af944fb24a2eca772b12e0476c004b","3612d75f67cd4fe3c995e6bac8746732d99c3057f2d2a06b7fecebd8c5323a71","4329b1241f8a1de335086e3298eca10a26a4c1ba7a128d28645cc029b5226d2b","4f5173f0ff6487aa44ba01c3c9532a65d53fcb9e5bbf34d3a5fd7eb24fdaa7c9","58862e1865e214903f9220d7b384954015f8378d5609940ad53f63d8ce67c01b","7fdcabf811695900719c72f678ca078d2c2b0595dde6eacb56d0ba17f605b74e","9f5d389b1e40daa180c439bfc0b815f33a39199c018bdfda5cc8a5621bd0d7d1","9f9e62f73307a73b30ac135e91999e36095cd9a9b0ffe3e71b22574e72ddbc5b","ad7558011516edb4812c878c272d0ced3e3ae6496b4596a644dd011865ba456d","b23e65022c161b33d4f90aaab99c3ebe326463c4a54e136c484884591e9b07a1","c26eeaa6e17b6500a85dc0107c7ab66c9aba805f6f37731b39c075250a6fd5c8","c61e1329e4361c93277d108ca672e4fb8543793c2b29dfbc5273573803333769","cb71b50f03fc9ae9f51770664ea565f4cc5d01980a3f08008d980ecd4d59bd1a","cbe37e08c6445c7ea067822515ed9a3799426ec450893627a2ba1229c139ab71","d7e922813d05b1b7b40ddfcd02be4e219a5e5ea655bbf812a14bbeac2fba122c","e6b68a56b12962bb21f056577180d19351b4679333d7940436654a3e0fa77564","eba39c059326c15fd67b8aee6a00872b441aa6a3079caf701ec41ad54812038b","fe1566ab77a096d73745f6a5ebecc37a6038fd93b98988502a56790459f4a3d8"],"recordQualifiers":{},"scopeLabel":"OMIM:619705","sourceIds":["OMIM:619705"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-91a634031e19fe32178c"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0030252","HP:0004432","HP:0012389","HP:0002136","HP:0033542","HP:0002110","HP:0100280"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":19,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":19,"sourceGroups":{"published":19}},"features":[{"hpoId":"HP:0030252","label":"Absent circulating B cells","primary":true},{"hpoId":"HP:0004432","label":"Agammaglobulinemia","primary":true},{"hpoId":"HP:0012389","label":"Appendicular hypotonia","primary":true},{"hpoId":"HP:0002136","label":"Broad-based gait","primary":true},{"hpoId":"HP:0033542","label":"Bronchial wall thickening","primary":true},{"hpoId":"HP:0002110","label":"Bronchiectasis","primary":true},{"hpoId":"HP:0100280","label":"Crohn's disease","primary":true},{"hpoId":"HP:0004315","label":"Decreased circulating IgG concentration","primary":false},{"hpoId":"HP:0002850","label":"Decreased circulating IgM concentration","primary":false},{"hpoId":"HP:0030388","label":"Decreased class-switched memory B cell proportion","primary":false},{"hpoId":"HP:0010976","label":"Decreased total B cell count","primary":false},{"hpoId":"HP:0001875","label":"Decreased total neutrophil count","primary":false},{"hpoId":"HP:0010862","label":"Delayed fine motor development","primary":false},{"hpoId":"HP:0002194","label":"Delayed gross motor development","primary":false},{"hpoId":"HP:0001263","label":"Global developmental delay","primary":false},{"hpoId":"HP:0001639","label":"Hypertrophic cardiomyopathy","primary":false},{"hpoId":"HP:0005133","label":"Right ventricular dilatation","primary":false},{"hpoId":"HP:0005180","label":"Tricuspid regurgitation","primary":false},{"hpoId":"HP:0001716","label":"Wolff-Parkinson-White syndrome","primary":false}],"ledeHtml":"Any immunodeficiency in which the cause of the disease is a mutation in the FNIP1 gene, characterized by onset of recurrent viral and bacterial infections, particularly with encapsulated bacteria, and hypertrophic cardiomyopathy in the first months or years of life. Immunologic workup typically shows decreased circulating B cells and hypo- or agammaglobulinemia, sometimes with neutropenia or T-cell lymphocytosis, although laboratory findings may be variable among patients. Ig replacement therapy is beneficial. Cardiac involvement can also include atrial septal defect, valvular insufficiency, and pre-excitation syndrome. Rare myopathic or neurologic involvement has been reported, but these features are not consistently part of the disorder and may be related to other genetic defects. Disruption of Folliculin Interacting Protein 1 alters the essential metabolic regulators AMPK and mTOR, resulting in profound B-cell deficiency, hypertrophic cardiomyopathy, and pre-excitation syndrome.","mondoId":"MONDO:0100432","node":{"canonicalSlug":"fnip1-associated","comparisons":[{"documentSha256":"ca9266523cbfecb52107d0d7d2903ee90efb6348502ad21cdfe172d59ec31348","key":"legacy-fnip1-associated","kind":"legacy","label":"FNIP1-associated syndrome","memberIds":["MONDO:0100432"],"mondoId":"MONDO:0100432","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/fnip1-associated.ca9266523cbfecb52107d0d7d2903ee90efb6348502ad21cdfe172d59ec31348.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","matchMethod":"same-ontology-node","name":"FNIP1-associated syndrome","paragraphs":["Any immunodeficiency in which the cause of the disease is a mutation in the FNIP1 gene, characterized by onset of recurrent viral and bacterial infections, particularly with encapsulated bacteria, and hypertrophic cardiomyopathy in the first months or years of life. Immunologic workup typically shows decreased circulating B cells and hypo- or agammaglobulinemia, sometimes with neutropenia or T-cell lymphocytosis, although laboratory findings may be variable among patients. Ig replacement therapy is beneficial. Cardiac involvement can also include atrial septal defect, valvular insufficiency, and pre-excitation syndrome. Rare myopathic or neurologic involvement has been reported, but these features are not consistently part of the disorder and may be related to other genetic defects. Disruption of Folliculin Interacting Protein 1 alters the essential metabolic regulators AMPK and mTOR, resulting in profound B-cell deficiency, hypertrophic cardiomyopathy, and pre-excitation syndrome."],"scope":"exact","source":"MONDO","upstream":"https://orcid.org/0000-0002-7371-8158, https://orcid.org/0000-0003-0113-912X, OMIM:619705, PMID:32181500","url":"https://monarchinitiative.org/MONDO:0100432"},"ownColumnKeys":["population-91a634031e19fe32178c"],"publication":"published","relationships":[{"kind":"parent","label":"immunodeficiency disease","mondoId":"MONDO:0021094","slug":null}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"pending"},"records":[{"frequencyKind":"count","key":"0b8c54c72e791a03837b0208d351edb23b0e0805465cfb254bafd8e0d03ecf3b","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:619705","disease_name":"Immunodeficiency 93 and hypertrophic cardiomyopathy","evidence":"PCS","frequency_raw":"1/3","hpo_id":"HP:0001263","is_excluded":false,"label":"Global developmental delay","onset_id":null,"reference":"PMID:32905580","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"0bcf8b056380cb72e41bb56960a4431542af944fb24a2eca772b12e0476c004b","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:619705","disease_name":"Immunodeficiency 93 and hypertrophic cardiomyopathy","evidence":"PCS","frequency_raw":"2/3","hpo_id":"HP:0030388","is_excluded":false,"label":"Decreased class-switched memory B cell proportion","onset_id":null,"reference":"PMID:32181500","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"3612d75f67cd4fe3c995e6bac8746732d99c3057f2d2a06b7fecebd8c5323a71","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:619705","disease_name":"Immunodeficiency 93 and hypertrophic cardiomyopathy","evidence":"PCS","frequency_raw":"2/3","hpo_id":"HP:0002850","is_excluded":false,"label":"Decreased circulating IgM concentration","onset_id":null,"reference":"PMID:32181500","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"4329b1241f8a1de335086e3298eca10a26a4c1ba7a128d28645cc029b5226d2b","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:619705","disease_name":"Immunodeficiency 93 and hypertrophic cardiomyopathy","evidence":"PCS","frequency_raw":"2/3","hpo_id":"HP:0004315","is_excluded":false,"label":"Decreased circulating IgG concentration","onset_id":null,"reference":"PMID:32181500","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"4f5173f0ff6487aa44ba01c3c9532a65d53fcb9e5bbf34d3a5fd7eb24fdaa7c9","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:619705","disease_name":"Immunodeficiency 93 and hypertrophic cardiomyopathy","evidence":"PCS","frequency_raw":"6/6","hpo_id":"HP:0001639","is_excluded":false,"label":"Hypertrophic cardiomyopathy","onset_id":null,"reference":"PMID:32181500;PMID:32905580","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"58862e1865e214903f9220d7b384954015f8378d5609940ad53f63d8ce67c01b","raw":{"aspect":"P","body_system":"respiratory","disease_id":"OMIM:619705","disease_name":"Immunodeficiency 93 and hypertrophic cardiomyopathy","evidence":"IEA","frequency_raw":"1/3","hpo_id":"HP:0002110","is_excluded":false,"label":"Bronchiectasis","onset_id":null,"reference":"PMID:32905580","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"7fdcabf811695900719c72f678ca078d2c2b0595dde6eacb56d0ba17f605b74e","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:619705","disease_name":"Immunodeficiency 93 and hypertrophic cardiomyopathy","evidence":"PCS","frequency_raw":"2/3","hpo_id":"HP:0012389","is_excluded":false,"label":"Appendicular hypotonia","onset_id":null,"reference":"PMID:32181500","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"9f5d389b1e40daa180c439bfc0b815f33a39199c018bdfda5cc8a5621bd0d7d1","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:619705","disease_name":"Immunodeficiency 93 and hypertrophic cardiomyopathy","evidence":"PCS","frequency_raw":"2/3","hpo_id":"HP:0002136","is_excluded":false,"label":"Broad-based gait","onset_id":null,"reference":"PMID:32181500","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"9f9e62f73307a73b30ac135e91999e36095cd9a9b0ffe3e71b22574e72ddbc5b","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:619705","disease_name":"Immunodeficiency 93 and hypertrophic cardiomyopathy","evidence":"PCS","frequency_raw":"2/3","hpo_id":"HP:0001875","is_excluded":false,"label":"Decreased total neutrophil count","onset_id":null,"reference":"PMID:32181500","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"ad7558011516edb4812c878c272d0ced3e3ae6496b4596a644dd011865ba456d","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:619705","disease_name":"Immunodeficiency 93 and hypertrophic cardiomyopathy","evidence":"PCS","frequency_raw":"3/3","hpo_id":"HP:0002194","is_excluded":false,"label":"Delayed gross motor development","onset_id":null,"reference":"PMID:32181500","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"b23e65022c161b33d4f90aaab99c3ebe326463c4a54e136c484884591e9b07a1","raw":{"aspect":"P","body_system":"digestive","disease_id":"OMIM:619705","disease_name":"Immunodeficiency 93 and hypertrophic cardiomyopathy","evidence":"PCS","frequency_raw":"1/3","hpo_id":"HP:0100280","is_excluded":false,"label":"Crohn's disease","onset_id":null,"reference":"PMID:32905580","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"c26eeaa6e17b6500a85dc0107c7ab66c9aba805f6f37731b39c075250a6fd5c8","raw":{"aspect":"P","body_system":"respiratory","disease_id":"OMIM:619705","disease_name":"Immunodeficiency 93 and hypertrophic cardiomyopathy","evidence":"PCS","frequency_raw":"1/3","hpo_id":"HP:0033542","is_excluded":false,"label":"Bronchial wall thickening","onset_id":null,"reference":"PMID:32905580","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"c61e1329e4361c93277d108ca672e4fb8543793c2b29dfbc5273573803333769","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:619705","disease_name":"Immunodeficiency 93 and hypertrophic cardiomyopathy","evidence":"PCS","frequency_raw":"3/3","hpo_id":"HP:0004432","is_excluded":false,"label":"Agammaglobulinemia","onset_id":null,"reference":"PMID:32905580","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"cb71b50f03fc9ae9f51770664ea565f4cc5d01980a3f08008d980ecd4d59bd1a","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:619705","disease_name":"Immunodeficiency 93 and hypertrophic cardiomyopathy","evidence":"PCS","frequency_raw":"2/3","hpo_id":"HP:0001716","is_excluded":false,"label":"Wolff-Parkinson-White syndrome","onset_id":null,"reference":"PMID:32181500","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"cbe37e08c6445c7ea067822515ed9a3799426ec450893627a2ba1229c139ab71","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:619705","disease_name":"Immunodeficiency 93 and hypertrophic cardiomyopathy","evidence":"PCS","frequency_raw":"2/3","hpo_id":"HP:0010976","is_excluded":false,"label":"Decreased total B cell count","onset_id":null,"reference":"PMID:32181500","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"d7e922813d05b1b7b40ddfcd02be4e219a5e5ea655bbf812a14bbeac2fba122c","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:619705","disease_name":"Immunodeficiency 93 and hypertrophic cardiomyopathy","evidence":"PCS","frequency_raw":"3/3","hpo_id":"HP:0030252","is_excluded":false,"label":"Absent circulating B cells","onset_id":null,"reference":"PMID:32905580","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"e6b68a56b12962bb21f056577180d19351b4679333d7940436654a3e0fa77564","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:619705","disease_name":"Immunodeficiency 93 and hypertrophic cardiomyopathy","evidence":"PCS","frequency_raw":"3/3","hpo_id":"HP:0010862","is_excluded":false,"label":"Delayed fine motor development","onset_id":null,"reference":"PMID:32181500","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"eba39c059326c15fd67b8aee6a00872b441aa6a3079caf701ec41ad54812038b","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:619705","disease_name":"Immunodeficiency 93 and hypertrophic cardiomyopathy","evidence":"PCS","frequency_raw":"1/3","hpo_id":"HP:0005180","is_excluded":false,"label":"Tricuspid regurgitation","onset_id":null,"reference":"PMID:32905580","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"fe1566ab77a096d73745f6a5ebecc37a6038fd93b98988502a56790459f4a3d8","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:619705","disease_name":"Immunodeficiency 93 and hypertrophic cardiomyopathy","evidence":"PCS","frequency_raw":"1/3","hpo_id":"HP:0005133","is_excluded":false,"label":"Right ventricular dilatation","onset_id":null,"reference":"PMID:32905580","source_release":"2026-06-23"},"sourceGroups":["published"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0100432\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>same-ontology-node</dd><dt>Upstream attribution</dt><dd>https://orcid.org/0000-0002-7371-8158, https://orcid.org/0000-0003-0113-912X, OMIM:619705, PMID:32181500</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Any immunodeficiency in which the cause of the disease is a mutation in the FNIP1 gene, characterized by onset of recurrent viral and bacterial infections, particularly with encapsulated bacteria, and hypertrophic cardiomyopathy in the first months or years of life. Immunologic workup typically shows decreased circulating B cells and hypo- or agammaglobulinemia, sometimes with neutropenia or T-cell lymphocytosis, although laboratory findings may be variable among patients. Ig replacement therapy is beneficial. Cardiac involvement can also include atrial septal defect, valvular insufficiency, and pre-excitation syndrome. Rare myopathic or neurologic involvement has been reported, but these features are not consistently part of the disorder and may be related to other genetic defects. Disruption of Folliculin Interacting Protein 1 alters the essential metabolic regulators AMPK and mTOR, resulting in profound B-cell deficiency, hypertrophic cardiomyopathy, and pre-excitation syndrome.</p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0100432\" rel=\"noreferrer\">MONDO</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"fnip1-associated","sourceDocuments":[{"name":"MONDO: FNIP1-associated syndrome","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0100432"}],"sourceNote":"","synonyms":["absent B cells, agammaglobulinemia, and hypertrophic cardiomyopathy syndrome","FNIP1 deficiency","IMD93","immunodeficiency 93 and hypertrophic cardiomyopathy","immunodeficiency and hypertrophic cardiomyopathy","immunodeficiency with cardiomyopathy and pre-excitation syndrome"],"takeawayHtml":"","title":"FNIP1-associated syndrome"},"schemaVersion":1}
